Bone augmentation using a synthetic hydroxyapatite/silica oxide‐based and a xenogenic hydroxyapatite‐based bone substitute materials with and without recombinant human bone morphogenetic protein‐2
- 19 August 2014
- journal article
- research article
- Published by Wiley in Clinical Oral Implants Research
- Vol. 26 (5) , 592-598
Abstract
Aim: To test whether or not bone regeneration using deproteinized bovine bone mineral (DBBM) is comparable to hydroxyapatite/silica oxide (HA/SiO) and to test the effect of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) as an adjunct to DBBM for localized bone regeneration.Materials and methods: In each of the 10 rabbits, 4 titanium cylinders were placed on the external cortical plates of their calvaria. Four treatment modalities were randomly allocated: (i) empty, (ii) HA/SiO, (iii) DBBM, and (iv) DBBM plus rhBMP‐2 (DBBM/BMP). The animals were sacrificed at week 8. Descriptive histology and histomorphometric assessment using a superimposed test grid of points and cycloids were performed.Results: The mean number of points of the test grid coinciding with bone within the cylinder reached 124 ± 35 bone points for empty controls, 92 ± 40 bone points for DBBM, 98 ± 44 bone points for synthetic HA/SiO, and 146 ± 34 bone points DBBM/BMP. The P‐value for DBBM with and without BMP reached a borderline statistical significance of 0.051. However, the area of bone regeneration within the cylinders peaked for DBBM/BMP and was statistically significantly higher compared with empty cylinders (P < 0.05). The bone‐to‐bone substitute contact ranged between 32.9% ± 21.7 for DBBM, 39.6 ± 18.4% for HA/SiO, and 57.8% ± 10.2 for DBBM/BMP. The differences between DBBM/BMP and controls (DBBM, HA/SiO) were statistically significant (P < 0.05).Conclusions: DBBM and HA/SiO rendered comparable amounts of bone regeneration. The addition of rhBMP‐2 to DBBM resulted in more favorable outcomes with respect to the area of bone regeneration and to bone‐to‐implant contact, thereby indicating the potential of this growth factor to enhance bone regeneration within this animal model.Keywords
This publication has 33 references indexed in Scilit:
- Implantation of silicon dioxide-based nanocrystalline hydroxyapatite and pure phase beta-tricalciumphosphate bone substitute granules in caprine muscle tissue does not induce new bone formationHead & Face Medicine, 2013
- Synthetic bone substitute material comparable with xenogeneic material for bone tissue regeneration in oral cancer patients: First and preliminary histological, histomorphometrical and clinical resultsAnnals of Maxillofacial Surgery, 2013
- Bone regeneration using a synthetic matrix containing enamel matrix derivateClinical Oral Implants Research, 2011
- Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute materialClinical Oral Implants Research, 2010
- Ridge Augmentation Using Recombinant Bone Morphogenetic Protein‐2 Techniques: An Experimental Study in the CanineJournal of Periodontology, 2010
- Evaluation of Parathyroid Hormone Bound to a Synthetic Matrix for Guided Bone Regeneration Around Dental Implants: A Histomorphometric Study in DogsJournal of Periodontology, 2010
- Sinus Lift Using a Nanocrystalline Hydroxyapatite Silica Gel in Severely Resorbed Maxillae: Histological Preliminary StudyClinical Implant Dentistry and Related Research, 2009
- Bone morphogenetic protein‐2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphateClinical Oral Implants Research, 2007
- Ridge augmentation by applying bioresorbable membranes and deproteinized bovine bone mineral: a report of twelve consecutive casesClinical Oral Implants Research, 2007
- Effect of Recombinant Human Bone Morphogenetic Protein‐2 in an Absorbable Collagen Sponge With Space‐Providing Biomaterials on the Augmentation of Chronic Alveolar Ridge DefectsJournal of Periodontology, 2004